高级搜索
张婷, 杨潇逸, 潘黎姿, 徐东紫, 陈娟, 欧阳昭连. 基于专利引文网络的神经母细胞瘤治疗领域技术前沿识别研究[J]. 肿瘤防治研究, 2023, 50(9): 866-872. DOI: 10.3971/j.issn.1000-8578.2023.23.0175
引用本文: 张婷, 杨潇逸, 潘黎姿, 徐东紫, 陈娟, 欧阳昭连. 基于专利引文网络的神经母细胞瘤治疗领域技术前沿识别研究[J]. 肿瘤防治研究, 2023, 50(9): 866-872. DOI: 10.3971/j.issn.1000-8578.2023.23.0175
ZHANG Ting, YANG Xiaoyi, PAN Lizi, XU Dongzi, CHEN Juan, OUYANG Zhaolian. Exploring Technology Frontiers for Neuroblastoma Treatment from Perspective of Patent Citation Network[J]. Cancer Research on Prevention and Treatment, 2023, 50(9): 866-872. DOI: 10.3971/j.issn.1000-8578.2023.23.0175
Citation: ZHANG Ting, YANG Xiaoyi, PAN Lizi, XU Dongzi, CHEN Juan, OUYANG Zhaolian. Exploring Technology Frontiers for Neuroblastoma Treatment from Perspective of Patent Citation Network[J]. Cancer Research on Prevention and Treatment, 2023, 50(9): 866-872. DOI: 10.3971/j.issn.1000-8578.2023.23.0175

基于专利引文网络的神经母细胞瘤治疗领域技术前沿识别研究

Exploring Technology Frontiers for Neuroblastoma Treatment from Perspective of Patent Citation Network

  • 摘要:
    目的 基于专利引文网络识别神经母细胞瘤治疗领域技术前沿。
    方法 本研究通过神经母细胞瘤治疗领域的专利分析,以引文网络中的高被引专利及高被引论文作为研究对象,采用文本聚类的方法对其施引专利的标题、摘要进行分析,以识别技术前沿;采用社会网络分析的方法,从度中心性、中介中心性、接近中心性及特征向量中心性等指标对高被引专利引文网络进行分析以识别核心专利。
    结果 神经母细胞瘤治疗领域共有专利申请6 240项,含有专利引文71 304件,期刊论文引文88 698件。基于专利引文网络共识别出4个技术前沿,分别是药物靶点、药物设计、肿瘤适应证扩展和基因表达调控。基于期刊论文引文网络识别出3个技术前沿:药物靶点、药物设计和肿瘤适应证扩展。
    结论 神经母细胞瘤治疗领域技术开发持续活跃。药物靶点和药物设计是神经母细胞瘤治疗领域最受关注的技术前沿。本研究可以从情报学角度为神经母细胞瘤治疗技术研究提供一定的借鉴和参考。

     

    Abstract:
    Objective To explore the technology frontiers for neuroblastoma treatment from the perspective of patent citation network.
    Methods Through patent analysis for neuroblastoma treatment, highly cited patents and highly cited papers in the citation network were taken as the research objects. The title and abstract of the citing patents were analyzed by text clustering to identify the technology frontiers. Through social network analysis, the core patents were identified from the indices of degree centrality, betweenness centrality, closeness centrality, and eigenvector centrality.
    Results A total of 6240 patent applications for neuroblastoma treatment were found, including 71304 patent citations and 88698 journal-article citations. Four technology frontiers were identified based on patent citation network, namely, drug target, drug design, tumor-indication expansion, and gene-expression regulation. Three technology frontiers were identified based on journal-article citation network. They were drug target, drug design, and tumor-indication expansion.
    Conclusion The development of technology for neuroblastoma treatment continues to be active. Drug target and drug design are the most important technology frontiers. This study could provide certain reference for neuroblastoma treatment from the perspective of information science.

     

/

返回文章
返回